Sickle Cell Anemia affects over 70,000 adults in the United States, many being Black American men and women.
The trauma associated with this disease is often unbearable for some and totally intolerable others; for both groups, hope is on the way, manifesting itself in the form of a new groundbreaking procedure that might obliterate an ailment for which there used to be little to no aid.
A joint effort by members of Johns Hopkins University and the National Institutes of Health have developed a new bone marrow transplant method that is designed to be less painful and invasive yet more effective than its predecessors.
Nine of ten patients have been cured using the new method thus far.
Adults that display severe cases of the disease could not undergo treatment due to it proving too harsh a process for them.
Currently 2 million Americans, 1 in 12 Black Americans, carry the trait that causes Sickle Cell. 1 in 500 and 1 in every 1,000 Black and Hispanic births are to a child that has the disease.
To date, 200 children have been cured of Sickle Cell Anemia due to the new treatment method.
